Advanced Medical Optics to Present at the Morgan Stanley Third Annual Global Healthcare Unplugged Conference

Advanced Medical Optics to Present at the Morgan Stanley Third
Annual Global Healthcare Unplugged Conference 


SANTA ANA, Calif., April 28  /PRNewswire-FirstCall/ -- Advanced Medical Optics,
Inc. (AMO) (NYSE:AVO), a global leader in ophthalmic surgical devices and eye
care products, today announced that President and Chief Executive Officer James
V. Mazzo will present an overview of the company and review current guidance at
the Morgan Stanley Third Annual Healthcare Unplugged Conference in Miami on
Thursday, May 5, 2005, at 8:45 a.m. EDT.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO )

To access an audio webcast of the presentation via the internet, please visit
AMO's Investors/Media site at http://www.amo-inc.com/.

About Advanced Medical Optics (AMO)

AMO is a global leader in the development, manufacturing and marketing of
ophthalmic surgical and eye care products.  The company focuses on developing a
broad suite of innovative technologies and devices to address a wide range of
eye disorders.  Products in the ophthalmic surgical line include intraocular
lenses, phacoemulsification systems, viscoelastics, microkeratomes and related
products used in cataract and refractive surgery.  AMO owns or has the rights
to such ophthalmic surgical product brands as ReZoom(TM), Phacoflex(R),
Clariflex(R), Array(R), Sensar(R), CeeOn(R), Tecnis(R) and Verisyse(TM)
intraocular lenses, Sovereign(R) and Sovereign(R) Compact(TM)
phacoemulsification systems with WhiteStar(TM) technology, Amadeus(TM) and
Amadeus(TM) II microkeratomes, Healon(R) and Vitrax(R) viscoelastics, and the
Baerveldt(R) glaucoma shunt.  Products in the contact lens care line include
disinfecting solutions, daily cleaners, enzymatic cleaners and lens rewetting
drops.  Among the contact lens care product brands the company possesses are
COMPLETE(R) Moisture PLUS(TM), COMPLETE(R) Blink-N-Clean(R), Consept(R)F,
Consept(R) 1 Step, Oxysept(R) 1 Step, UltraCare(R), Ultrazyme(R), Total Care(R)
and blink(TM) branded products.  Amadeus is a licensed product of, and a
trademark of, SIS, Ltd.  OptiEdge(TM) is a registered trademark of Ocular
Sciences.  AMO is based in Santa Ana, California, and employs approximately
3,000 worldwide.  The company has operations in about 20 countries and markets
products in approximately 60 countries.  For more information, visit the
company's Web site at http://www.amo-inc.com/.

   Investor Contact:
   Erika Richmond
   [phone]
   

http://www.newscom.com/cgi-bin/prnh/20050324/AMOLOGO

http://photoarchive.ap.org/

DATASOURCE: Advanced Medical Optics, Inc.



CONTACT:  Investors, Erika Richmond of Advanced Medical Optics, Inc.,

[phone], 



Web site:  http://www.amo-inc.com/

Copyright